This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Access Bio, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Hyoungsoo Kim: Innovator in Diagnostic Assay Devices
Introduction
Hyoungsoo Kim is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of diagnostic assay devices, holding 3 patents that focus on innovative methods for detecting various pathogens.
Latest Patents
Hyoungsoo Kim's latest patents include a diagnostic assay device featuring a microreactor. This device is designed to detect the presence of an analyte in a sample solution. It operates by forming a sample solution containing the analyte, flowing it through the microreactor in a first direction to create an analyte-capture molecule complex. The sample solution is then transferred to an absorbent strip pad, which allows it to flow in a second direction that crosses the first. This process indicates the presence of the analyte-capture molecule complex. The diagnostic devices can be utilized to identify pathogens such as SARS-Cov2, RSV, influenza A, and influenza B in patient samples.
Career Highlights
Hyoungsoo Kim is currently associated with Access Bio, Inc., where he continues to develop innovative diagnostic solutions. His work has been instrumental in advancing the capabilities of diagnostic devices, particularly in the context of public health.
Collaborations
Hyoungsoo Kim collaborates with talented individuals in his field, including Young Ho Choi and Jungho Back. Their combined expertise contributes to the development of cutting-edge diagnostic technologies.
Conclusion
Hyoungsoo Kim's contributions to the field of diagnostic assay devices highlight his role as an innovator in medical technology. His patents reflect a commitment to improving diagnostic methods and enhancing public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
